Skip to main content
Premium Trial:

Request an Annual Quote

New director to extend EBI's reach

Premium

Janet Thornton got her start in physics, but escaped as soon as she could. After earning a degree in the field, she switched to biophysics and began studying protein structures. The thousands of structures that were discovered gave her “a wonderful playground to play in over the last 30 years.”

Thornton’s newest playground is the European Bioinformatics Institute, where she was recently appointed research director. She’ll take a five-year unpaid leave from her joint teaching positions at University College and Birkbeck College in London with the possibility of staying on longer at EBI.

Working with EBI is nothing new to Thornton, who has consulted for the institute and dealt extensively with the protein database there. As more funds become available from the European Union, EMBL, and the Wellcome Trust, Thornton plans to establish new research groups during her tenure. “The challenge is to recruit some new people,” she says. She speculates that by the end of her five-year term, the staff might double its current number of 130.

Another goal is to promote the integration of EBI’s five major data resources so users around the world can tap in once and get the answers they need, rather than having to use each resource independently. Thornton will also try to extend EBI’s reach on the industry front. “We have an industry club which involves big pharma, but at the moment we don’t do a lot for the smaller companies,” she adds.

Thornton replaces Michael Ashburner, who will return to a full-time job at the University of Cambridge. He will, however, continue in the role of consultant to EBI and will work closely with Thornton.

— Meredith Salisbury

The Scan

Just Breathing

A new analysis suggests that most Mycobacterium tuberculosis is spread by aerosols from breathing, rather than by coughing, the New York Times reports.

Just Like This One

NPR reports that the World Health Organization has hired a South African biotech company to recreate mRNA vaccine for SARS-CoV-2 that is similar to the one developed by Moderna.

Slow Start

The Wall Street Journal reports that Biogen's Alzheimer's disease treatment had revenues for July through September that totaled $300,000.

Genome Research Papers on Cancer Chromatin, Splicing in the Thymus, Circular RNAs in Cancer

In Genome Research this week: analysis of bivalent chromatin sites, RBFOX splicing factors' role in thymic epithelial cells, and more.